These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 8909102)

  • 1. Labelling, control and radiopharmacological evaluation of 99mTc-adenosine 5'-diphosphate (99mTc-ADP) as tumour seeking agent.
    León AS; Rey AM; Leon ET; Savio EO; Kremer C; Lacava CJ; Nappa AN; Chiozzone RN; Campos ED
    Q J Nucl Med; 1996 Jun; 40(2):170-5. PubMed ID: 8909102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 99mTc-ADP: a potential agent for in vivo tumor detection.
    León ET; Rey AM; Savio EO; López JJ; Kremer E; León AS
    J Nucl Biol Med (1991); 1994 Dec; 38(4 Suppl 1):99-103. PubMed ID: 7632778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New bone-seeking agent: animal study of Tc-99m-incadronate.
    Shigematsu M; Shomi S; Iwao H; Ochi H
    Ann Nucl Med; 2002 Feb; 16(1):55-9. PubMed ID: 11922209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A technetium-99m-labelled cyclam acid porphyrin (CAP) for tumour imaging.
    Murugesa S; Shetty SJ; Srivastava TS; Noronha OP; Samuel AM
    Appl Radiat Isot; 2001 Nov; 55(5):641-6. PubMed ID: 11573797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scintigraphic imaging of the hypoxia marker (99m)technetium-labeled 2,2'-(1,4-diaminobutane)bis(2-methyl-3-butanone) dioxime (99mTc-labeled HL-91; prognox): noninvasive detection of tumor response to the antivascular agent 5,6-dimethylxanthenone-4-acetic acid.
    Siim BG; Laux WT; Rutland MD; Palmer BN; Wilson WR
    Cancer Res; 2000 Aug; 60(16):4582-8. PubMed ID: 10969810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, optimization and biological evaluation of 99mTc-digoxin as possible cardiac imaging agent.
    Bokhari TH; Roohi S; Hina S; Saeed S
    Pak J Pharm Sci; 2018 Jan; 31(1):19-24. PubMed ID: 29348079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uptake of radiolabelled herceptin by experimental mammary adenocarcinoma.
    Wiercioch R; Balcerczak E; Byszewska E; Mirowski M
    Nucl Med Rev Cent East Eur; 2003; 6(2):99-103. PubMed ID: 14737722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies of 99mTc-BnAO (HL-91): a non-nitroaromatic compound for hypoxic cell detection.
    Zhang X; Melo T; Ballinger JR; Rauth AM
    Int J Radiat Oncol Biol Phys; 1998 Nov; 42(4):737-40. PubMed ID: 9845087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 99mTc-labeled field bean protease inhibitor can function as an efficient tumor detecting agent.
    Murugesan S; Banerji AP; Noronha OP; Samuel AM; Fernandes AO
    Indian J Exp Biol; 2001 Aug; 39(8):742-7. PubMed ID: 12018574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 99mTc-ethylenedicysteine-folate: a new tumor imaging agent. Synthesis, labeling and evaluation in animals.
    Ilgan S; Yang DJ; Higuchi T; Zareneyrizi F; Bayhan H; Yu D; Kim EE; Podoloff DA
    Cancer Biother Radiopharm; 1998 Dec; 13(6):427-35. PubMed ID: 10851435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Synthesis and animal imaging of 99mTc-hydrazinonicotinamide-folate as a new folate receptor-targeted tumor imaging agent].
    Liu LQ; Wang SZ; Li F; Teng B; Wang KZ; Qiu FC
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Dec; 28(6):786-9. PubMed ID: 17260467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, biodistribution and effects of farnesyltransferase inhibitor therapy on tumour uptake in mice of 99mTc labelled epidermal growth factor.
    Cornelissen B; Kersemans V; Burvenich I; Oltenfreiter R; Vanderheyden JL; Boerman O; Vandewiele C; Slegers G
    Nucl Med Commun; 2005 Feb; 26(2):147-53. PubMed ID: 15657509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of chromatographic methods for quality control of DMSA complexes with 99mTc and 188Re at (III) and (V) oxidation states.
    Garnuszek P; Pawlak D; Maurin M; Jankovic D; Karczmarczyk U; Mikołajczak R
    Nucl Med Rev Cent East Eur; 2012 Aug; 15(2):95-100. PubMed ID: 22936501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiolabelling of glycosylated MFE-23::CPG2 fusion protein (MFECP1) with 99mTc for quantitation of tumour antibody-enzyme localisation in antibody-directed enzyme pro-drug therapy (ADEPT).
    Francis RJ; Mather SJ; Chester K; Sharma SK; Bhatia J; Pedley RB; Waibel R; Green AJ; Begent RH
    Eur J Nucl Med Mol Imaging; 2004 Aug; 31(8):1090-6. PubMed ID: 15029458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new technique of 99mTc-ciprofloxacin kit preparation.
    Kleisner I; Komarek P; Komarkova I; Konopkova M
    Nuklearmedizin; 2002 Oct; 41(5):224-9. PubMed ID: 12418309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and normal scintigraphic appearance of 99mTc aprotinin.
    Sojan SM; Smyth DR; Tsopelas C; Mudge D; Collins PJ; Chatterton BE
    Nucl Med Commun; 2005 Jun; 26(6):535-9. PubMed ID: 15891597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Technetium-99m-cyclam AK 2123: a novel marker for tumor hypoxia.
    Murugesan S; Shetty SJ; Noronha OP; Samuel AM; Srivastava TS; Nair CK; Kothari L
    Appl Radiat Isot; 2001 Jan; 54(1):81-8. PubMed ID: 11144256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 99mTc-labeling of colchicine using [99mTc(CO)3(H2O)3]+ and [99mTc triple bond N]2+ core for the preparation of potential tumor-targeting agents.
    Korde A; Satpati D; Mathur A; Mallia M; Banerjee S; Kothari K; Sarma HD; Choudhari P; Venkatesh M
    Bioorg Med Chem; 2006 Feb; 14(3):793-9. PubMed ID: 16289854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 99mTc-NC100692--a tracer for imaging vitronectin receptors associated with angiogenesis: a preclinical investigation.
    Edwards D; Jones P; Haramis H; Battle M; Lear R; Barnett DJ; Edwards C; Crawford H; Black A; Godden V
    Nucl Med Biol; 2008 Apr; 35(3):365-75. PubMed ID: 18355693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new 99mTc labelling method for leucocytes: in vitro and in vivo comparison with 99mTc-HMPAO.
    Welling M; Feitsma HI; Blok D; Calame W; Ensing GJ; Goedemans W; Pauwels EK
    Q J Nucl Med; 1995 Jun; 39(2):89-98. PubMed ID: 8574810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.